For research teamsHelp me find a study
Back to all studies
CompletedNCT00499863

MTS for ADHD

This study is completed in the United States. It is testing MTS for ADHD.

ADHDDrugFrom 13 Years to 17 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether MTS may be useful for adolescents experiencing ADHD.

What would participation involve?

Participants may receive MTS, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adolescents with ADHD. Because it involves minors, a parent or guardian may need to be involved.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateJuly 2007
Recruitment status
Completed
Enrollment listed in the registry
217
Sponsor
Noven Therapeutics
Sponsor type
Biotech company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 13 Years to 17 Years
Official registry ID
NCT00499863
Official title
A Phase IIIb, Randomized, Double-Blind, Multi-Center, Parallel-Group, Placebo-Controlled, Dose Optimization Study, Designed to Evaluate the Efficacy and Safety of MTS in Adolescents Aged 13-17 Years With ADHD

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 32 sites
  • Melmed Center
    Scottsdale, Arizona
    Site status: Not listed — confirm with the team
  • Bay Area Research Institute
    Lafayette, California
    Site status: Not listed — confirm with the team
  • Elite Clinical Trials Inc.
    Wildomar, California
    Site status: Not listed — confirm with the team
  • Sarkis Clinical Trials
    Gainesville, Florida
    Site status: Not listed — confirm with the team
  • Miami Research Associates
    South Miami, Florida
    Site status: Not listed — confirm with the team
  • Northwest Behavioral Research Ctr
    Roswell, Georgia
    Site status: Not listed — confirm with the team
  • Mountain West Clinical Trials, LLC
    Eagle, Idaho
    Site status: Not listed — confirm with the team
  • Vince and Associates Clinical Research
    Overland Park, Kansas
    Site status: Not listed — confirm with the team
  • Shire Clinical Research Site
    Lexington, Kentucky
    Site status: Not listed — confirm with the team
  • Four Rivers Clinical Research, Inc.
    Paducah, Kentucky
    Site status: Not listed — confirm with the team
  • Rochester Center for Behavioral Medicine
    Rochester Hills, Michigan
    Site status: Not listed — confirm with the team
  • Clinical Neurophysiology Services, PC
    Troy, Michigan
    Site status: Not listed — confirm with the team
  • CRI Worldwide
    Clementon, New Jersey
    Site status: Not listed — confirm with the team
  • Triangle Neuropsychiatry
    Durham, North Carolina
    Site status: Not listed — confirm with the team
  • Dakota Clinic/Innovis health
    Fargo, North Dakota
    Site status: Not listed — confirm with the team
  • Odyssey Research
    Minot, North Dakota
    Site status: Not listed — confirm with the team
  • University Hospitals Case Medical Center
    Cleveland, Ohio
    Site status: Not listed — confirm with the team
  • Oregon Center for Clinical Investigations, Inc.
    Eugene, Oregon
    Site status: Not listed — confirm with the team
  • OCCI, Inc
    Portland, Oregon
    Site status: Not listed — confirm with the team
  • Shire Clinical Research Site
    Media, Pennsylvania
    Site status: Not listed — confirm with the team
  • CRI Worldwide
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Rhode Island Hospital
    Providence, Rhode Island
    Site status: Not listed — confirm with the team
  • CNS Healthcare
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • FutureSearch Trials
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Claghorn-Lesem Research, Ltd.
    Bellaire, Texas
    Site status: Not listed — confirm with the team
  • Westex Clinical Investigations
    Lubbock, Texas
    Site status: Not listed — confirm with the team
  • Cerebral Research, LLC
    San Antonio, Texas
    Site status: Not listed — confirm with the team
  • Vermont Clinical Study Center
    Burlington, Vermont
    Site status: Not listed — confirm with the team
  • NeuroScience, Inc.
    Herndon, Virginia
    Site status: Not listed — confirm with the team
  • Adolescent Health Center
    Midlothian, Virginia
    Site status: Not listed — confirm with the team
  • Northwest Clinical Research Center
    Friday Harbor, Washington
    Site status: Not listed — confirm with the team
  • Eastside Therapeutic Resource
    Kirkland, Washington
    Site status: Not listed — confirm with the team

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT00499863. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving methylphenidate transdermal system, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with adhd; age range: From 13 Years to 17 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Noven Therapeutics, which appears to be a biotech company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.